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ABSTRACT
Human immunodeficiency virus type 1 (HIV-1) gene
transcription is characterized by two temporally dis-
tinct phases. While the initial phase relies solely on
cellular transcription factors, thesubsequentphase is
activated by the viral Tat transactivator. We have pre-
viously reported that the subsequent phase of viral
gene transcription can be repressed by the chicken
ovalbumin upstream promoter transcription factor
(COUP-TF)-interacting protein 2 (CTIP2) in human
microglial cells [O. Rohr, D. Lecestre, S. Chasserot-
Golaz, C. Marban, D. Avram, D. Aunis, M. Leid and
E. Schaeffer (2003), J. Virol., 77, 5415–5427]. Here,
we demonstrate that CTIP proteins also repress the
initial phase of HIV-1 gene transcription, mainly sup-
ported by the cellular transcription factors Sp1 and
COUP-TF in microglial cells. We report that CTIP2
represses Sp1- and COUP-TF-mediated activation of
HIV-1 gene transcription and viral replication as a
result of physical interactions with COUP-TF and
Sp1 in microglial nuclei. Using laser confocal
microscopy CTIP2 was found to colocalize with
Sp1, COUP-TF and the heterochromatin-associated
protein Hp1a, which is mainly detected in transcrip-
tionally repressed heterochromatic region. Moreover,
we describe that CTIP2 can be recruited to the HIV-1
promoter via its association with Sp1 bound to the
GC-box sequences of the long terminal repeat
(LTR). Since our findings demonstrate that CTIP2
interacts with the HIV-1 proximal promoter, it is likely
that CTIP2 promotes HIV-1 gene silencing by forc-
ing transcriptionally repressed heterochromatic
environment to the viral LTR region.
INTRODUCTION
Infection of the central nervous system (CNS) by the human
immunodeficiency virus type 1 (HIV-1) is associated with a
spectrum of neurological damage, ranging from acute enceph-
alopathies to AIDS dementia (1,2). The CNS constitutes a
sanctuary and a reservoir for the virus despite antiretroviral
therapies (3). Microglial cells, the CNS resident macrophages,
may be particularly suitable for this purpose because they are
long lived, HIV productive for several weeks and relatively
immune to virus-induced cytopathology [reviewed in (4)].
Since microglial cells are the primary targets of HIV-1
productive infection within the CNS (5,6), investigation on
HIV-1 repression in these cells are important for the global
understanding of HIV pathogenesis and for the development of
anti-HIV strategies.
HIV-1 gene transcription is a key step in the control of the
virus life cycle [reviewed in (7)]. Viral gene transcription is
characterized by two temporally distinct phases. The initial
phase occurs immediately after integration and relies solely on
cellular transcription factors. Most of the transcripts cannot
elongate efficiently and terminate rapidly after initiation.
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However, a few transcripts elongate throughout the genome,
resulting in transcription and expression of the viral transactiv-
ator Tat. The subsequent phase of transcription occurs when
enough Tat protein has accumulated. Tat binds to TAR,
recruits pTEFb complex and dramatically stimulates HIV-1
gene transcription [reviewed in (8,9)].
We have previously studied some of the cellular transcrip-
tion factors that impact HIV-1 gene transcription in
microglial cells. Chicken ovalbumin upstream promoter tran-
scription factor I (COUP-TFI)/Ear3, Arp1/COUP-TFII and
Ear2/COUP-TFIII proteins are the three members of the
COUP-TF orphan nuclear receptors superfamily. We have
described that the orphan nuclear receptor COUP-TFI/Ear3
(10,11) is expressed in numerous human CNS cell lineages,
including microglial cells. COUP-TFI is an activator of HIV-
1 gene transcription in oligodendrocytes (12), microglia (13)
and T lymphocytes (14). Moreover, we have revealed the
importance of functional interactions between the nuclear
factor for interleukin 6 (NF-Il6), Sp1 and COUP-TFI in
the regulation of the initial phase of HIV-1 gene transcription
in brain cells (15). The transcription factor Sp1 is one of the
crucial cellular proteins for efficient HIV-1 gene transcription
(16–18). A number of studies have reported that Sp1 can
serve as an anchor for indirect binding of other transcription
factors to the HIV-1 long terminal repeat (LTR) region. In all
cell types, an interaction between Sp1 and Tat is required for
optimal HIV-enhancer activation (19). Moreover, Sp1 is able
to recruit the Cyclin T1 subunit of P-TEFb to the LTR, which
helps to bypass a requirement for TAR/Tat and promotes
processive transcription without Tat (20). In microglial
cells, the main HIV-1 target cells in the brain (6), Sp1
anchors COUP-TF (13) and NF-IL6 (15) to the three GC-
boxes adjacent to the viral CATA box. The CATA box is
used instead of the TATAA box for optimal HIV-1 gene
transcription and replication (21). We have shown that
Sp1 and COUP-TF interact and cooperate in the transcrip-
tional activation of HIV-1 gene transcription (13). Moreover,
COUP-TF can substitute to Sp1 association with the viral Tat
protein to restore Tat function and HIV-1 replication in
microglial cells (22). These results highlight the key roles
of Sp1 and COUP-TF proteins in HIV-1 expression in
microglial cells.
Members of the COUP-TF family have been shown to bind
related zinc finger proteins named COUP-TF-interacting
protein 1 (CTIP1) and 2 (CTIP2) that are highly expressed
in brain and immune systems (23,24). Recent results support
the selective contribution of these proteins in the development
and function of the nervous and immune systems (24). We
recently described that the nuclear cofactor CTIP2 inhibits the
subsequent phase of HIV-1 gene transcription and viral rep-
lication by relocating the viral transactivator Tat protein to
transcriptionally inactive regions of chromatin via Hp1a (25).
In the present work, CTIP2 overexpression leads to the repres-
sion of HIV-1 replication. In contrast, CTIP1 was unable to
affect Tat function. Using confocal microscopy to visualize
Tat subcellular distribution in the presence of each CTIP
proteins, we found that CTIP2, but not CTIP1, leads to the
disruption of Tat nuclear localization and to its recruitment
within CTIP2-induced nuclear ball-like structures. In addition,
we showed that CTIP2 and Hp1a associate with Tat to form
a three-protein complex. These findings suggest that the
inhibition of HIV-1 expression by CTIP2 correlates with
the recruitment of Tat within CTIP2-induced structures and
its relocalization within inactive regions of chromatin.
On line with this study, we noticed that CTIP proteins also
affect HIV-1 gene transcription in the absence of Tat, which
means that CTIP proteins may also impair endogenous cellular
transcription factor functions of importance for the initial
phase of HIV-1 gene transcription.
Here, we report that CTIP proteins repress HIV-1 gene
transcription via the proximal LTR region which binds
Sp1 and COUP-TF transactivators. Since COUP-TF and
Sp1 cellular transcription factors are two of the major con-
tributors to HIV-1 gene transcription in microglial cells, we
have postulated that Sp1- and COUP-TF-mediated LTR-
driven activation may be impaired by CTIP1 and CTIP2.
We report here that both CTIP1 and CTIP2 repress Sp1-
and COUP-TF-mediated stimulation of HIV-1 gene expres-
sion. Since the CTIP2 repressive activity is much stronger
than the CTIP1-mediated inhibition of HIV-1 replication, we
focused our study on CTIP2. CTIP2-mediated repression of
Sp1 and COUP-TF functions results from direct physical
interactions of these cellular transcription factors with
CTIP2. Association with CTIP2 forces Sp1 and COUP-TF
relocation to CTIP2-induced subnuclear structures containing
the heterochromatin-associated protein Hp1a. Moreover,
CTIP2 can be recruited to the HIV-1 promoter by a physical
association with Sp1 bound to the GC-box regions of the
LTR. Since Sp1 or COUP-TF transcription factors are neces-
sary for the Tat function in microglial cells (22), CTIP2-
mediated repression of COUP-TF and Sp1 functions may
largely contribute to the previously described CTIP2-
mediated impairment of Tat activity and viral replication
in microglial cells (25).
MATERIALS AND METHODS
Plasmids
Most of the constructs used in our assays were described
previously: HIV-1 (LAI) 50 LTR chloramphenicol acetyltrans-
ferase (pLTR-CAT) (22), pGC-WAP-CAT (26), pLTR-LUC
287–535 (13), pLTR-CAT mutGC and pLTR-CAT DGC (22),
pcDNA3, full-length constructs HA-CTIP1, Flag-CTIP2 and
GST-CTIP2 (23), deletions constructs Flag-CTIP2 (25), RSV-
COUP-TF, CMV-Sp1, GST-COUP-TF1, GST-COUP-TF2
and GST-COUP-TF3 (13).
Several plasmids were kindly provided by the following
investigators: GST-Sp1 constructs were provided by
H. Rotheneder (Vienna, Austria) (27) and pLTR-LUC by
C. Van Lint (Gosselies, Belgium). pNL4-3 (28) was obtained
through the AIDS Research and Reference Reagent Program,
division of AIDS, National Institute of Allergy and Infectious
Diseases (NIAID), NIH.
To construct RFP-CTIP2, the expression vector Flag-CTIP2
was digested with EcoRI and the CTIP2 insert was subcloned
into the EcoRI site of the pDSRed vector (Clontech). The
GFP-Sp1 was constructed by isolating the XhoI–HindIII
Sp1 insert from the GST-Sp1 expression vector and subcloned
into the XhoI–HindIII sites of the pEGFP-C1 vector
(Clontech).
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Cell culture
The human microglial (provided by M. Tardieu, Paris, France)
(29), the TZM-bl (30–32) and the HEK 293T cell lines were
maintained in DMEM containing 10% fetal calf serum and
100 U/ml penicillin–streptomycin.
Viral replication
Microglial cells cultured in 12-well plates were transfected
using the calcium phosphate coprecipitation method with
HIV-1 pNL4-3 (1.5 mg), CMV-Sp1 (1 mg) or RSV-COUP-
TF (1 mg) plasmids and the indicated HA-CTIP1 or Flag-
CTIP2 expression vectors (0.1, 0.5 or 1 mg). Total amounts
of DNA were identical in each experiment. Compensations
were made by adding the corresponding empty vectors. Each
transfection was carried out in duplicate and repeated a
minimum of three separate times with two different plasmid
preparations. HIV-1 replication was monitored as described
previously (25).
CAT assays
Microglial cells cultured in 12-well plates were transfected
using the calcium phosphate coprecipitation method with
pLTR-CAT (3 mg), pGC-WAP-CAT (3 mg) or pLTR-CAT
DGC (3 mg), CMV-Sp1 (1 mg) or RSV-COUP-TF (1 mg)
plasmids and the indicated HA-CTIP1 or Flag-CTIP2 (0.1,
0.5 or 1 mg) expression vectors. Total amounts of DNA
were identical in each experiments. Compensations were
made by adding the corresponding empty vectors. Each trans-
fection was carried out in duplicate and repeated a minimum of
three separate times with two different plasmid preparations.
CAT assays were carried out using standard techniques.
Co-immunoprecipitation assays
Microglial cells cultured in 100 mm diameter dishes were
transfected using LipofectamineTM 2000 Reagent (Invitrogen)
with the indicated Flag-CTIP2 (30 mg). Twenty four hours
post-transfection, the cells were washed twice with cold
phosphate-buffered saline, harvested and prepared for nuclear
extracts (12). Nuclear proteins were first diluted in TNE buffer
[50 mM Tris, pH 8, 1% Nonidet, 2 mM EDTA, protease
inhibitors cocktail (Roche)], cleared with Protein A/G Plus-
Agarose (Santa Cruz Biotechnology) and finally incubated
overnight with primary antibodies: anti-Sp1 (Sigma), anti-
COUP-TF (kindly provided by J. E. Mertz, Madison, WI)
or anti-Hp1a (kindly provided by R. Losson, IGBMC,
Strasbourg, France). The extracts were then immunoprecipit-
ated by the addition of Protein A/G Plus-Agarose (Santa Cruz
Biotechnology). After extensive washing with TNE buffer, the
immunoprecipitates were processed for SDS–PAGE and
western blot analysis.
Glutathione S-transferase (GST) pull-down assays
Production of GST fusion proteins was described previously
(13) and visualized by Coomassie blue staining. The 35S-
labeled proteins were prepared by in vitro transcription and
translation using the TNT1 T7 Coupled Wheat Germ Extract
System (Promega). GST pull-down assays were performed as
described previously (25).
SDS–PAGE and western blot analysis
SDS–PAGE was performed using standard techniques.
Proteins were detected using antibodies directed against the
Flag epitope (M2 mouse monoclonal; Sigma), against the
COUP-TF protein (kindly provided by J. E. Mertz) and against
the Sp1 protein (Sigma). Proteins were visualized by chemi-
luminescence using the Super Signal Chemiluminescence
Detection System (Pierce).
Electrophoretic mobility shift assays (EMSA)
The probe used in our experiments has been described previ-
ously (13) and corresponds to the three Sp1 binding sites of the
HIV-1 proximal LTR region. Once produced, GST fusion
proteins were eluted in glutathione buffer (50 mM Tris,
pH 8, 20 mM reduced glutathione). Purified Sp1 (Promega)
and GST fusion proteins were then incubated with the 32P-
labeled probe in binding buffer (20 mM HEPES, pH 7.9, 1 mM
MgCl2, 60 mM KCl, 0.5 mM EDTA, 1 mM DTT and 10%
glycerol) at 4C for 15 min. For supershift experiments, GST
fusion proteins were incubated with the primary antibodies:
anti-COUP-TF (kindly provided by J. E. Mertz), anti-CTIP2
and anti-Sp1 (Santa Cruz Biotechnology) for 16 h before
adding the probe. EMSA assays were performed as described
previously (25).
Indirect immunofluorescence and confocal microscopy
Microglial cells cultured in 48-well plates were transfected or
not using LipofectamineTM 2000 Reagent (Invitrogen) with
Flag-CTIP2, RFP-CTIP2 and/or GFP-Sp1 expression vectors.
Cells were fixed and permeabilized as described previously
(25). The coverslips were then incubated for 1 h at room
temperature with primary antibodies directed against
COUP-TF (Santa Cruz Biotechnology or kindly provided
by J. E. Mertz), Sp1 (sigma) and Hp1a proteins and/or against
the Flag epitope (M2 mouse monoclonal; Sigma). The primary
immunocomplexes were revealed by CY2- or CY3-labeled
secondary anti-species antibodies. The stained cells were ana-
lyzed by confocal microscopy using a Zeiss laser scanning
microscope (model 510 invert) equipped with a Planapo oil
(63·) immersion lens (numerical aperture = 1.4).
Chromatin immunoprecipitation (ChIP) assays
TZM-bl and HEK 293T cells cultured in 100 mm diameter
dishes were transfected using the calcium phosphate coprecip-
itation method with the indicated pLTR-LUC, pLTR-CAT
mutGC and Flag-CTIP2 (30 mg) expression vector. ChIP
assays were performed using the ChIP Assay Kit (Upstate)
48 h post-transfection. The primary antibodies used for the
ChIP were anti-Sp1 (Upstate), anti-Hp1a (Upstate), anti-
COUP-TF (Santa Cruz Biotechnology) and anti-Flag M2
mouse monoclonal (Sigma). DNA was subjected to PCR
amplification using a 50 primer (50-GATAAGGTAGAA-
GAGGCC-30) corresponding to the LTR sequence located
293 nt downstream of the transcriptional start site and a 30
primer (50-CTAACCAGAGAGACCCAGTAC-30) corres-
ponding to a region just upstream of the transcriptional start
site. The resulting PCR product (307 bp) was analyzed by
agarose gel electrophoresis and ethidium bromide staining.
Three separate experiments were performed.
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RESULTS
CTIP1 and CTIP2 proteins repress HIV-1 gene
transcription via the LTR proximal region
As previously shown, CTIP1 and CTIP2 proteins inhibited the
LTR-driven transcription in transient transfection assays
(Figure 1, lanes 2 and 3) (25). To delineate the LTR region
responsible for CTIP1- and CTIP2-mediated HIV-1 gene tran-
scriptional repression, microglial cells were transfected with a
50 deleted pLTR-CAT reporter plasmid in the presence or
absence of CTIP1 and CTIP2 expression vectors. Deletion
of the 50 region downstream of the two proximal GC-box
sequences did not affect CTIP1 and CTIP2 ability to repress
LTR-driven CAT activity (Figure 1, lanes 5 and 6), indicating
that CTIP proteins repressive function can be mediated by the
proximal region of the LTR encompassing two GC-box
sequences, the CATA sequence (21) and the TAR region.
We have previously observed that the cellular transcription
factors, Sp1 and Sp3, are directly bound to the LTR GC-box
sequences in microglial cells (13). Moreover, the orphan
nuclear receptor COUP-TF is indirectly anchored to this
region via its association with Sp1 (13). We have largely
described that Sp1 and COUP-TF transcription factors are
two of the major contributors to the initial phase of HIV-1
gene transcription in microglial cells (9,13,22). Taken
together, these findings strongly suggest that CTIP repressive
activity may result from impairment of endogenous Sp1 and
COUP-TF protein functions.
CTIP1 and CTIP2 cofactors inhibit Sp1- and
COUP-TF-mediated activation of HIV-1 gene
transcription and related viral replication
To decipher the mechanism whereby CTIP proteins affect the
initial phase of HIV-1 gene transcription, we investigated the
impacts of CTIP proteins on Sp1 and COUP-TF functions.
Microglial cells were transfected with pLTR-CAT plasmid
together with the vectors expressing COUP-TF (Figure 2A)
or Sp1 (Figure 2B) proteins and with increasing amounts of
HA-CTIP1 or Flag-CTIP2 expression vectors. The two pro-
teins were able to repress COUP-TF- and Sp1-mediated
stimulations of CAT activity. As a control, we performed
western blot experiments, indicating that COUP-TF and Sp1
expressions were not downregulated but slightly upregulated
by the cofactors. Since overexpression of COUP-TF and Sp1
stimulates HIV-1 gene expression, this modest upregulation
could not be responsible for the CTIPs repressive function. To
correlate CTIP1 and CTIP2 repressive activity on LTR-driven
transcription to the level of HIV-1 replication, we studied
their impacts on Sp1- and COUP-TF-mediated stimulations
of viral replication. Cells were transfected with HIV-1 pNL4-
3 and COUP-TF (Figure 2C) or Sp1 (Figure 2D) expression
vectors in the presence of increasing amounts of CTIP1 or
CTIP2 expression vectors. The level of viral replication was
investigated by quantifying p24 Gag expression in the culture
supernatants 2 days after transfection. While both CTIP1 and
CTIP2 inhibited COUP-TF (Figure 2C) and Sp1 (Figure 2D)
activation of HIV-1 NL4-3 replication, the strongest repres-
sion was observed with CTIP2 (Figure 2C and D, lanes 6–8),
indicating that the repressing activity of CTIP2 on HIV-1
replication cannot be explained only by its previously
described capacity to repress the viral Tat protein (25).
These results strongly suggest that CTIP1 and CTIP2 repress
the initial phase of HIV-1 gene transcription through direct or
indirect interactions with endogenous Sp1 and COUP-TF
proteins.
The HIV-1 Tat function and the subsequent phase of the
HIV-1 gene transcription also depend on Tat association with
Sp1 or COUP-TF in microglial cells (22). Since CTIP2-
mediated repressive activities are much stronger than those
observed for CTIP1 and since CTIP2, but not CTIP1, inhibits
the subsequent phase of the HIV-1 gene transcription, we
focused our mechanistic investigation on CTIP2.
CTIP2 interacts with COUP-TF and Sp1 in vitro
by two interfaces
To decipher the mechanism whereby CTIP2 represses COUP-
TF and Sp1 stimulatory activities, we first examined whether
these proteins were able to interact in vitro. GST pull-down
assays were performed with in vitro translated 35S-labeled
CTIP2 and equal amounts of full-length or truncated GST-
COUP-TF and GST-Sp1 fusion proteins (Figure 3A). Results
show that CTIP2 bound specifically to GST-COUP-TF and
GST-Sp1 (Figure 3A, lanes 3 and 8, respectively) but not to the
control GST protein (Figure 3A, lanes 2 and 7, respectively).
Figure 1. CTIP1 and CTIP2 proteins repress HIV-1 gene transcription via the proximal LTR region. Microglial cells were transfected with 3mg of pLTR-CAT or 3mg
of pLTR-CAT (287–535) in the presence or absence of 1 mg of HA-CTIP1 or Flag-CTIP2. Two days post-transfection, CAT activities were measured and expressed
relative to the CAT activity obtained with pLTR-CAT alone with the standard deviations indicated (values correspond to an average of at least three independent
experiments performed in duplicate).
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Approximately 2–5% and 1–2% of the 35S-labeled CTIP2
interacted with GST-COUP-TF and GST-Sp1, respectively.
Moreover, the 49–148 region of COUP-TF (Figure 3A, lane
5) and the 622–788 region of Sp1 (Figure 3A, lane 11) were
still able to mediate association with CTIP2, indicating that
CTIP2 interacted with the N-terminal region of COUP-TF and
the C-terminal region of Sp1, both of which include zinc finger
domains.
To precisely delineate the region of CTIP2 protein that
associates with Sp1 and COUP-TF, GST pull-down assays
were performed with full-length GST-COUP-TF or GST-Sp1
fusion proteins and a series of in vitro-translated 35S-labeled
full-length and deletion mutants of CTIP2 (Figure 3B). The
full-length as well as deletion mutants starting at position 350,
610 and 717 did mediate interaction with GST-COUP-TF
(Figure 3B, lane 6) and GST-Sp1 (Figure 3B, lane 3) but
not with the control GST protein (Figure 3B, lanes 2 and
5). These results show that CTIP2 is able to interact with
Sp1 and COUP-TF via its C-terminal zinc finger domain
region. We have previously shown that CTIP2 harbors two
independent interaction domains with the viral Tat protein
(25). This prompted us to determine whether an additional
Figure 2. CTIP1 and CTIP2 inhibit Sp1- and COUP-TF-mediated activation of HIV-1 gene transcription and related viral replication. Microglial cells were
cotransfected with 3 mg of pLTR-CAT (A and B) or 3 mg of pNL4-3 (C and D), 1 mg of RSV-COUP-TF (A and C) or CMV-Sp1 (B and D) expression vectors and
increasing amounts of HA-CTIP1 or Flag-CTIP2 (0.1, 0.5 or 1mg). (A and B) Two days post-transfection, CAT activities were measured and expressed relative to the
value obtained with pLTR-CAT alone with the standard deviation indicated (values correspond to an average of at least three independent experiments performed in
duplicate). Western blot experiments were performed on nuclear extracts with antibodies directed against COUP-TF or Sp1 proteins as indicated. (C and D) Two days
post-transfection, culture supernatants were analyzed for p24 Gag contents and expressed relative to the value obtained with pNL4-3 alone taken as 1. Depending on
the cell confluency, this value varied between 500 and 5000 pg/ml. Values correspond to an average of at least three independent experiments performed in duplicate.
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interaction interface was located in the N-terminal or the
central region of CTIP2. To this end, GST pull-down experi-
ments were performed with additional deletion constructs. As
expected, the deletion mutant 350–716 was not able to interact
with COUP-TF and Sp1, confirming that the C-terminal region
of CTIP2 containing residues 717–813 mediates binding to
these transcription factors. However, the 1–354 and the 145–
434 constructs appeared to be able to restore interactions,
suggesting that the central region of CTIP2 located between
the residues 145 and 354 might be sufficient for COUP-TF and
Sp1 association.
Thus, these findings indicate that CTIP2 interacts in vitro
with the zinc finger domains of COUP-TF and Sp1 by two
interfaces located in the central region (residues 145–354) and
the C-terminal region (residues 717–813).
CTIP2 colocalizes with Sp1 and COUP-TF within
Hp1a-associated structures
To visualize the association of CTIP2 with Sp1 and COUP-TF
within the nucleus, Flag-CTIP2 transfected microglial
cells were observed by immunofluorescence confocal laser
A
B
Figure 3. CTIP2 interacts in vitro with COUP-TF and Sp1 by two interfaces. (A) Upper panels: schematic representation of the COUP-TF and Sp1 proteins; lower
panels: GST pull-down assays were performed with 35S-labeled CTIP2 incubated with GST (lanes 2 and 7) or GST fusion proteins of the indicated COUP-TF domains
(lanes 3–5) or Sp1 domains (lanes 8–11). Approximately 1% of the total 35S-labeled CTIP2 obtained was loaded as input control (lanes 1 and 6). (B) GST pull-down
assays were performed with 35S-labeled full-length or truncated CTIP2 proteins incubated with GST (lanes 2 and 5), GST-COUP-TF (lane 6) or GST-Sp1 (lane 3)
fusion proteins. Approximately 1% of the total 35S-labeled proteins used were loaded as input control (lanes 1 and 4). Representative Coomassie stainings of GST,
GST-Sp1 and GST-COUP-TF proteins were presented (B lower panels).
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microscopy (Figure 4A). As previously described (25), anti-
Flag immunostaining of Flag-CTIP2 revealed the formation of
CTIP2-induced nuclear ball-like structures in microglial cells
nuclei (Figure 4A, images 3, 8 and 13). Flag-CTIP2 appeared
as concentrated at the periphery but absent within the struc-
tures. Interestingly, observations of RFP-CTIP2 (Figure 4B,
images 1 and 5) fusion protein revealed the presence of
CTIP2 at the periphery but also within the previously
described nuclear structures, suggesting that the Flag epitopes
within these ball-like structures were probably not accessible
to the anti-Flag antibodies. To control the nuclear location of
RFP-CTIP2 expression, cells were transfected with RFP-
CTIP2 and GFP-Lamin B expression vectors. As previously
described (25), CTIP2-induced nuclear structures were located
in the nucleus of microglial cells (C. Marban and O. Rohr,
unpublished data). In the absence of CTIP2, endogenous
A
B
Figure 4. CTIP2 colocalizes with Sp1 and COUP-TF within Hp1a-associated structures. (A) Microglial cells were transfected or not with Flag-CTIP2 as indicated.
After being treated, endogenous Sp1, COUP-TF and Hp1aproteins were immunodetected with primary anti-COUP-TF (Santa Cruz Biotechnology) (images 1 and 2),
anti-Sp1 (images 6 and 7) and anti-Hp1a antibodies (images 11 and 12). Overexpressed Flag-CTIP2 was detected with antibodies directed against the Flag epitope
(images 3, 8 and 13). The primary immunocomplexes were revealed by CY2- or CY3-labeled anti-species secondary antibodies (green or red staining). Mask column
(images 5, 10 and 15) shows the colocalized CY2 and CY3 stainings. (B) Microglial cells expressing RFP-CTIP2 (image 1) and GFP-Sp1 (image 3) were subjected to
endogenous COUP-TF immunodetection with anti-COUP-TF antibodies (kindly provided by J. E. Mertz). COUP-TF immunocomplexes were stained by CY5- (blue
staining) labeled anti-species secondary antibodies (image 2). Pattern of RFP-CTIP2 and GFP-Sp1 expressed alone are presented on images 5 and 6, respectively.
(A and B) Coverslips were subjected to confocal microscopy analysis. Bar, 10 mm.
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COUP-TF and Sp1 proteins were expressed in the nucleo-
plasm with a speckled and diffused staining pattern (images
1 and 6). Moreover, in the presence of Flag-CTIP2, these
transcription factors were at least partially located to
CTIP2-induced nuclear structures (Figure 4A, images 2 and
7). Endogenous Sp1 (Figure 4A, images 9 and 10) and COUP-
TF (Figure 4A, images 4 and 5) proteins colocalized with
CTIP2 at the periphery of the immunostained structures. Up
to 87 and 70% of endogenous COUP-TF and Sp1 proteins
colocalized with CTIP2, respectively. No staining was
observed inside the ball-like structures. We have reported
that CTIP2 relocates the viral Tat transactivator to the
heterochromatin-associated protein Hp1a (25). Endogenous
Hp1a exhibited a diffused and speckled nuclear distribution
in the absence of CTIP2 (Figure 4A, image 11). To visualize
the presence of Hp1a in CTIP2-induced structures in the
absence of Tat, we performed immunodetection of endogen-
ous Hp1a in microglial cells expressing Flag-CTIP2. As
shown in Figure 4A (images 14 and 15), endogenous Hp1a
colocalized with CTIP2, suggesting that endogenous COUP-
TF, Sp1 and Hp1a proteins are relocated to the same CTIP2-
induced nuclear structures. To address whether COUP-TF and
Sp1 also colocalized with CTIP2 inside the ball-like structures,
we performed immunodetection of the endogenous COUP-TF
protein with other different polyclonal antibodies (kindly
provided by J. E. Mertz) in the presence of RFP-CTIP2 and
GFP-Sp1 fusion proteins. As shown in Figure 4B (image 2),
endogenous COUP-TF was observed inside the structures,
confirming that the epitope accessibility to the antibodies is
determinant to COUP-TF immunodetection. Since RFP-
CTIP2 was expressed in ball-like structures (Figure 4B,
images 1 and 5), GFP-Sp1 expressed alone was localized in
the nucleoplasm with a diffused staining pattern (Figure 4B,
image 6). Moreover, in the presence of RFP-CTIP2, GFP-Sp1
is relocated to CTIP2-induced structures (Figure 4B, image 3).
COUP-TF and GFP-Sp1 relocation was not restricted to the
periphery of the CTIP2-induced nuclear structures, since they
were also detected inside the structures as shown by the pres-
ence of white staining resulting from colocalized red, blue and
green staining (Figure 4B, image 4). Thus, endogenous Sp1
proteins were probably relocated within the heterochromatic
structures too. However, they remained unaccessible to the
currently used antibodies (Figure 4A, images 7 and 9).
These results strongly suggest that the cellular transcription
factors, Sp1 and COUP-TF, associate with CTIP2 in
microglial cells.
CTIP2 interacts with Sp1, COUP-TF and Hp1a in
microglial cells
We have observed that CTIP2 colocalizes with Sp1, COUP-TF
and the heterochromatin-associated protein HP1a in
microglial cells. To test whether Sp1, COUP-TF, CTIP2 and
Hp1a are present in the same complex, we performed co-
immunoprecipitation experiments on microglial nuclear
extracts expressing or not the Flag-CTIP2 protein (Figure 5A).
Anti-Flag western blot immunodetections performed on anti-
COUP-TF (lanes 3 and 4), anti-Sp1 (lanes 6 and 7) and anti-
Hp1a (lanes 9 and 10) immunoprecipitated nuclear extracts
indicated that CTIP2 interacted with COUP-TF (lane 4), Sp1
(lane 7) and Hp1a (lane 10) in microglial cells. As a control,
experiments performed on CTIP2 non-expressing extracts
(lanes 3, 6 and 9) or on non-immune serum (NIS) immuno-
precipitated nuclear extracts (lanes 2, 5 and 8) confirmed the
specificity of the Flag immunodetection and the specificity of
the COUP-TF, Sp1 and Hp1a immunoprecipitation experi-
ments, respectively. Thus, CTIP2 may be able to recruit a
protein complex, including the three proteins in the nucleus
of microglial cells. To address how CTIP2 links COUP-TF and
Sp1 to Hp1a, we performed competition pull-down assays
(Figure 5B). GST-COUP-TF and GST-Sp1 fusion proteins
were incubated with both 35S-labeled CTIP2 145–434 and
CTIP2 717–813 in the presence of increasing amounts of
35S-Hp1a. Results clearly show that CTIP2 145–434 remained
bound to GST-COUP-TF and GST-Sp1, while CTIP2 717–813
was displaced by Hp1a. This displacement increased the
amount of GST fusion proteins available for the CTIP2
145–434 binding. Hp1a competed for COUP-TF and Sp1
binding to the C-terminal domain of CTIP2. These findings
indicate that the 145–434 region of CTIP2 has a stronger
binding affinity for COUP-TF and Sp1 than the 717–813
domain, which preferentially binds Hp1a. Thus, CTIP2
may link COUP-TF and Sp1 bound to the 145–434 domain
and Hp1a bound to the 717–813 domain. To precisely exam-
ine the formation of a ternary complex between Sp1, COUP-
TF and CTIP2, we performed GST pull-down experiments of
mixed 35S-labeled-Sp1 and -COUP-TF proteins with GST-
CTIP2. As shown in Figure 5C, Sp1 and COUP-TF interacted
together with CTIP2. Moreover, addition of increasing
amounts of 145–434 CTIP2 or COUP-TF proteins did not com-
pete each other for Sp1 binding (Figure 5D). Thus, COUP-TF
and CTIP2 do not compete for Sp1 binding in vitro. Taken
together, those findings strongly suggest the formation of a
ternary complex occurring between Sp1, COUP-TF and CTIP2.
CTIP2 is anchored to the HIV-1 LTR by
direct interactions with Sp1 bound to the LTR
proximal region
CTIP proteins are DNA-binding proteins, which bind a
consensus sequence related to the canonical GC-box (33).
Moreover, we have previously described that COUP-TF activ-
ates HIV-1 transcription by direct protein–protein interactions
with Sp1 bound to the proximal region of HIV-1 LTR (13).
The association of CTIP2 with Sp1 and COUP-TF (Figure 5)
led us to examine how CTIP2 interacts with the HIV-1 LTR to
promote viral repression. To do that, we performed EMSA
experiments with pure Sp1 proteins and bacterially produced
GST-CTIP2 and GST-COUP-TF proteins that were incubated
with a 32P-labeled probe corresponding to the three Sp1 bind-
ing sites (GC-box) of the HIV-1 LTR proximal region. As
expected, Sp1 bound to the probe to form a shifted nucleo-
proteic complex (Figure 6A, lanes 1 and 7). Interestingly,
addition of GST-CTIP2 (lane 2) or GST-COUP (lane 3) but
not GST (lane 4) separately promoted the formation of super-
shifted complexes, indicating that, as previously reported for
COUP-TF (13), CTIP2 was anchored to the LTR by a physical
interaction with Sp1. As a control, GST-COUP-TF and
GST-CTIP2 proteins, incubated alone, were unable to directly
interact with the probe (lanes 5 and 6). To confirm whether
COUP-TF, CTIP2 and Sp1 form a ternary complex, we per-
formed additional gel shift experiments in which increasing
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amounts of CTIP2 proteins were added to the binary
Sp1/COUP-TF complex (lanes 9 and 10). As shown, the shif-
ted complex formed by COUP-TF and Sp1 bound to the tem-
plate (lane 8) was supershifted by increasing the amount of
CTIP2 in a dose-dependent manner. Moreover, the intensity of
the supershifted complexes also increased with CTIP2 quant-
ity. Those findings are in favor of the formation of a ternary
complex anchored to the HIV-1 Sp1 binding sites. To precisely
examine this complex, the mixed three proteins were incub-
ated with their respective antibody. EMSA experiments
demonstrated that the complex observed in the presence of
the three proteins (Figure 6A, lane 10 and Figure 6B, lane 1)
was supershifted by the antibodies directed against CTIP2
(Figure 6B, lane 2) and COUP-TF (Figure 6B, lane 3) but
not by non-immune serum (Figure 6B, lane 5) confirming
the presence of the two proteins in the complex. Moreover,
incubation of the mixed three proteins with the anti-Sp1 anti-
bodies (Figure 6B, lane 4) inhibited the formation of the nuc-
leoprotein complex. Thus, impairing Sp1 binding to the
proxixmal region of the HIV-1 LTR results in the total aboli-
tion of the CTIP2 and COUP-TF ability to bind this region of
the viral promoter. These results confirm that both CTIP2 and
COUP-TF interact with Sp1 bound to the LTR in vitro.
Previously published EMSA experiments performed with nuc-
lear extracts of microglial cells have revealed that this region
of the viral promoter binds the cellular transcription factors,
Sp1 and Sp3, in microglial cells (13). EMSA experiments
performed with nuclear extracts of microglial cells expressing
CTIP2 could not allow us to observe CTIP2 indirect binding
to the LTR (C. Marban and O. Rohr, unpublished data). To
bypass this technical issue and to address whether CTIP2
interacts with the viral promoter in vivo, ChIP assays were
A
B
C D
Figure 5. CTIP2 interacts with COUP-TF, Sp1 and Hp1a in microglial cells. (A) Nuclear extracts of microglial cells expressing (lanes 2, 4, 5, 7, 8 and 10) or not (lanes
3, 6 and 9) Flag-CTIP2 were immunoprecipitated with antibodies directed against COUP-TF (lanes 3 and 4), Sp1 (lanes 6 and 7) or Hp1a (lanes 9 and 10) proteins.
Proteins were separated by SDS–PAGE and western blot analysis with anti-Flag antibodies were performed. (B) GST pull-down competition assays were performed
with equal amounts of 35S-labeled 145–434 and 717–813 CTIP2 proteins and increasing amounts of 35S-labeled Hp1a. Proteins were incubated with GST-COUP-TF
or GST-Sp1 fusion proteins as indicated. (C) GST pull-down assays were performed with equal amounts of 35S-labeled Sp1 and COUP-TF proteins and GST or GST-
CTIP2 fusion proteins as indicated. (D) GST pull-down competition assays were performed with the indicated amounts of 35S-labeled 145–434 CTIP2 and COUP-TF
proteins and GST-Sp1. (A–D) Approximately 1% of the total 35S-labeled proteins used were loaded as input control.
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conducted on TZM-bl cells, which contain a chromatin-
integrated LTR, and on transiently transfected HEK 293T
cells. Although the nature and/or the extent of chromatin
formation on transiently transfected templates likely differ
from that of chromosomal genes, previous reports have
validated ChIP studies in transiently transfected cells
(34,35). The amplified proximal LTR region includes the
three Sp1 binding sites but not the previously described
COUP-TF binding site (12). As expected, in the absence of
CTIP2, both endogenous Sp1 and COUP-TF interact with the
proximal LTR region in chromatin-integrated (Figure 6C) and
transiently transfected contexts (Figure 6D, left panel). More-
over, the presence of CTIP2 did not abolish Sp1 and COUP-TF
recruitment (Figure 6C, row 2 and Figure 6D, left panel row 3)
in agreement with the in vitro results described above. How-
ever, in the presence of CTIP2, a lesser extent of template was
A
C
D
B
Figure 6. CTIP2 is anchored to the HIV-1 LTR by direct interactions with Sp1 bound to the LTR proximal region. (A and B) EMSA experiments were performed
using purified Sp1, GST, GST-COUP-TF and GST-CTIP2 fusion proteins. Proteins were incubated with a 32P-labeled probe corresponding to the three Sp1 binding
sites located downstream of the LTR (LAI) TATAA sequence. (A) Increasing amounts of GST-CTIP2 proteins correspond to 5 ml (lane 9) and 10 ml (lane 10) of the
used GST-CTIP2 preparation. Supershift experiments performed in (B) were carried out with non-immune serum (lane 5) and with antibodies directed against CTIP2
(lane 2), COUP-TF (lane 3), and Sp1 (lane 4). The specific shifted and supershifted complexes are presented. (C) The TZM-bl cells, which contain a stably integrated
LTR, were transfected or not with 30 mg of the indicated Flag-CTIP2 expression vector. (D) HEK 293T cells were transfected with 5 mg of the indicated pLTR (left
panel) or pLTR mutGC (right panel) constructs and 10 mg of Flag-CTIP2 expression vector if indicated. (C and D) Input lanes correspond to positive controls
conduced with a fraction of the lysates used for the immunoprecipitation. Control lanes correspond to negative controls, in which immunoprecipitation reactions were
performed without antibodies. Anti-Flag, anti-Sp1, anti-COUP-TF and anti-Hp1a lanes represent amplification reactions from samples immunoprecipitated with the
indicated antibodies. Results are representative of three independent experiments.
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immunoprecipitated with the antibodies directed against Sp1
and COUP-TF in the context of the integrated LTR (Figure 6C,
row 2). The same observations were made with the antibodies
directed against Sp1 in the transiently transfected LTR context
(Figure 6D, left panel). As shown in Figure 6C and D (left
panel), CTIP2 interacted with the proximal region of the viral
promoter. In addition, mutation of the Sp1 binding sites abol-
ished the interaction of Sp1, COUP-TF and CTIP2 with this
region of the viral LTR (Figure 6D, right panel). Taken
together, our in vitro and in vivo findings suggest that the
Sp1-mediated recruitment of CTIP2 to the LTR occurs in a
cellular context. We could not detect Hp1a interactions with
the proximal region of the LTR in the absence of CTIP2,
suggesting that CTIP2 significantly increase the recruitment
of Hp1a to the HIV-1 proximal promoter (Figure 6D, left
panel). In addition, mutation of the Sp1 binding sites also
abolished CTIP2-mediated recruitment of Hp1a (Figure 6D,
right panel). Since Hp1a associates with heterochromatic
regions, it is likely that CTIP2 promotes transcriptionally
repressed heterochromatic environment to the viral LTR
region.
Sp1 binding sites are dominant and sufficient but not
absolutely necessary for transcriptional repression
mediated by CTIP2
To address the importance of the HIV-1 LTR GC-box
sequence for CTIP2 repressive function, we have transfected
microglial cells with the pGC-WAP-CAT reporter plasmid in
the presence of Sp1 and CTIP2 expression vectors (Figure 7A).
As expected, this heterologous promoter, containing three con-
sensus binding sites for Sp1, was highly inducible by ectopic
Sp1 overexpression (lane 3). Interestingly, overexpression of
CTIP2 also repressed Sp1-mediated transcriptional stimula-
tion in the context of the GC-WAP promoter (lane 4),
indicating that Sp1 binding sites were sufficient for CTIP2
activity. These results also suggest that CTIP2 may be able
to repress transcription of other Sp1-sensitive cellular genes.
To decipher whether CTIP2 repressive function is
exclusively mediated by the Sp1 binding sites, we have further
examined the LTR sequences responsible for CTIP2-mediated
transcriptional repression. To do that, we have transfected
microglial cells with pLTR-CAT vectors containing mutated
or deleted GC-boxes in the presence or absence of CTIP2. As
previously shown, CTIP2 expression resulted in a strong
repression of the basal LTR-driven CAT activity (Figure 7B,
lane 2). Mutation (lane 3) or deletion (lane 5) of the Sp1
binding sites resulted in a >90% impairment of the LTR tran-
scriptional activity, confirming the importance of endogenous
Sp1 and COUP-TF proteins, which bind to this region and
stimulate the initial phase of LTR-driven transcription in
microglial cells (13). Surprisingly, CTIP2 was still able to
repress the low remaining transcriptional activity of the
mutated (lane 4) and of the deleted (lane 6) LTR, suggesting
that CTIP2 may also affect HIV-1 gene transcription via
association with some other cellular transcription factors yet
to be characterized.
DISCUSSION
In a recent work, we have revealed the importance of the
cellular transcription factors, Sp1 and COUP-TFI/Ear3, in
the regulation of HIV-1 gene transcription and replication
in microglial cells (13). We have shown that the orphan nuc-
lear receptor COUP-TF associates and cooperates with Sp1 in
the activation of LTR-driven transcription. CTIP1 (Bcl11a,
Evi9) and CTIP2 (Bcl11b, Rit1b) are related transcriptional
regulatory proteins that have been shown to bind members of
A B
Figure 7. Sp1 binding sites are dominant and sufficient but not absolutely necessary for transcriptional repression mediated by CTIP2. (A) Microglial cells were
transfected with 3 mg of pGC-WAP-CAT reporter vector and 1 mg of expression vectors as indicated. (B) Microglial cells were transfected with 3 mg of pLTR-CAT,
pLTR-CAT mutGC or pLTR-CAT DGC and 1 mg of the indicated Flag-CTIP2 vector. Two days post-transfection, CAT activities were measured and expressed
relative to the value obtained with the reporter plasmids pGC-WAP-CAT or pLTR-CAT alone with the standard deviations indicated (values correspond to an average
of at least three independent experiments carried out in duplicate).
2328 Nucleic Acids Research, 2005, Vol. 33, No. 7
 by guest on N
ovem
ber 15, 2015
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
the COUP-TF family (23). In a more recent work, we have
described that the nuclear cofactor CTIP2 inhibits the
subsequent phase of HIV-1 gene transcription by relocating
the viral Tat protein to transcriptionally inactive regions of
chromatin via Hp1a (25).
Here, we addressed the mechanism whereby CTIP2 impairs
the initial phase (prior to Tat expression) of HIV-1 gene
transcription in microglial cells.
We report that CTIP proteins inhibit Sp1- and COUP-TF-
mediated activation of HIV-1 gene transcription and replica-
tion in microglial cells. To decipher the mechanism whereby
CTIP2 alters COUP-TF and Sp1 functions, we examined
whether these proteins interact in vitro and in cells. GST
pull-down experiments revealed that CTIP2 associates with
the N-terminal region of COUP-TF and with the C-terminal
region of Sp1 in vitro. In this way, CTIP2 presents two inter-
faces for Sp1 and COUP-TF interactions. COUP-TF and Sp1
proteins bind the central and the C-terminal region of CTIP2 in
vitro. These results are consistent with the previously reported
interface domains of Arp1 (COUP-TFII) with CTIP1 (23).
Confocal microscopy observations of COUP-TF and Sp1 loca-
tion in the presence or absence of CTIP2 reveal that CTIP2
colocalizes with COUP-TF and Sp1 within nuclear ball-like
structures. Moreover, the heterochromatin-associated protein
Hp1a is also present in these structures. There are three Hp1
protein family members in mammals, Hp1a, Hp1b and Hp1g .
The Hp1a isoform is mainly detected in transcriptionally
repressed heterochromatic region (36). Thus, the colocaliza-
tion of CTIP2 with endogenous Sp1, COUP-TF and Hp1a
proteins as reported here strongly suggests that these proteins
are relocated to transcriptionally inactive regions of
heterochromatin in microglial cells. Those CTIP2-induced
structures may represent a new class of nuclear structures
(25). Moreover, our observations may favor the hypothesis,
suggesting that the formation of nuclear bodies inhibits HIV-1
gene transcription by sequestering a variety of factors required
for transcriptional activation [reviewed in (37)].
Co-immunoprecipitation data indicate that the described
subnuclear colocalization results from physical interactions
between Sp1, COUP-TF, Hp1a and CTIP2 in the nucleus
of microglial cells. Since Hp1a, Sp1 and COUP-TF proteins
associate with CTIP2 in microglial cells, we address their
respective interaction interfaces in vitro. Our findings show
that the central zinc finger domain of CTIP2 may preferen-
tially bind Sp1 and COUP-TF proteins, while the C-terminal
region may bind to Hp1a. In the presence of the viral Tat
transactivator, CTIP2 also associates with Hp1a via its
C-terminal region. Taken together, these findings suggest a
permanent association of CTIP2 with Hp1a via its C-terminal
region. The central domain of CTIP2 may be reserved for the
interactions with the functionally repressed transcription
factors. Our observations indicate that COUP-TF and Sp1
could bind together to CTIP2 and that COUP-TF and
CTIP2 do not compete for Sp1 binding. Those findings suggest
the formation of a ternary complex, including COUP-TF, Sp1
and CTIP2 proteins. Thereby, CTIP2 links these transcrip-
tional activators to transcriptionally repressed heterochromatic
region. CTIP1 and CTIP2 proteins have been described as
sequence-specific DNA-binding proteins (33). The core-
binding site identified in this study is highly related to the
canonical GC-box sequence. Since Sp1 anchors COUP-TF
to the GC-box sequence of the viral LTR region (12), we
addressed how CTIP2 interacts with the HIV-1 promoter.
Our findings demonstrate that CTIP2 is not able to directly
bind the three viral GC-box sequences in vitro. CTIP2 is
recruited to the HIV-1 LTR via its association with Sp1
bound to this region. Moreover, CTIP2 is not in competition
with COUP-TF for Sp1-mediated anchorage to the viral pro-
moter, indicating that the three proteins are linked together to
the LTR in vitro. The ChIP experiments conducted in a cellular
context confirm that CTIP2, Sp1 and COUP-TF proteins do
bind the proximal region of the HIV-1 promoter in chromatin-
integrated and non-integrated contexts.
The surprising reduction of Sp1 or COUP-TF binding to the
viral promoter in the presence of CTIP2 apparently does not
agree with the in vitro observations. We show that Sp1 anchors
CTIP2 and COUP-TF to the HIV-1 LTR and that Sp1 binding
to the GC-box sequence is necessary for CTIP2 recruitment to
this region. Nevertheless, since Sp1 and COUP-TF proteins
are not accessible to their related antibodies in the CTIP2-
induced nuclear structures, one wonders whether the observa-
tion of reduced binding to the LTR may result from protein
sequestration and/or chromatin environment. ChIP experi-
ments also indicate that CTIP2 promotes Hp1a recruitment
to the LTR encompassing the Sp1 binding sequences. Muta-
tion of the Sp1 binding sites abolished this recruitment. Taken
together, these results suggest that the Sp1-mediated anchor-
age of CTIP2 to the HIV-1 LTR region may recruit a large
complex that promotes Hp1a association, heterochromatin
environment and viral gene transcriptional silencing. In Jurkat
cells, CTIP2 associates with the histone deacetylase SirT1 in a
large complex. CTIP2-mediated recruitment of SirT1 to pro-
moter template results in a deacetylation of the bound histones
H3 and H4 and in a transcriptional repression (35). The chro-
matin structure close to the HIV-1 gene promoter is involved
in viral post-integration latency phenomenon (38). Further
studies will be necessary to examine the CTIP2-recruited
complex that promotes HIV-1 gene silencing.
To control whether the CTIP2 repressive function is medi-
ated by Sp1 binding sites, we have examined its ability to
repress a heterologous promoter containing three consensus
GC-boxes. Our findings reveal that GC-box sequences are
sufficient for CTIP2-mediated repression of Sp1 stimulation,
suggesting that CTIP2 may impact the transcriptional activity
of other GC-box containing promoters. In agreement with
these observations, CTIP2 is still able to repress LTR-
driven transcriptional activity of a LTR deleted downstream
of the GC-box sequences. Recruitment of CTIP1 to the tem-
plate by a COUP-TF family member has been found to result
in a transcriptional repression of a reporter gene harboring a
COUP-TF binding site (23). In the context of the HIV-1
promoter, deletion of the previously described COUP-TF
binding site did not impact CTIP2 repressive function. More-
over, EMSA and ChIP experiments demonstrate that CTIP2
interacts with the proximal region of the LTR excluding the
COUP-TF binding sequence. Taken together, these findings
indicate that the COUP-TF binding sequence, located down-
stream to the GC-box region, might not be implicated in the
CTIP2 repressive functions. As widely reported, deletion of
the LTR GC-box region results in a drastic (>90%) reduction
of the LTR-driven transcriptional activity (13–15,22). These
observations confirm the crucial contribution of Sp1 and
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COUP-TF transcription factors to support viral gene transcrip-
tion in microglial cells. Moreover, they highlight the import-
ance of CTIP2-mediated repression of Sp1 and COUP-TF
protein functions. Most of the 80% CTIP2-mediated reduction
of the basal transcriptional level may be charged on to this
repressive activity. Surprisingly, CTIP2 is still able to repress
the 10% remaining transcriptional activity driven by a GC-box
deleted LTR, suggesting that CTIP2 may also be able to
repress the expression of mutated strains of virus. This remain-
ing activity represents <10% of the global CTIP2-mediated
repressive activity.
Nevertheless, we have previously suggested that COUP-TF
restores the viral Tat function in the context of a GC-box
mutated LTR by anchoring Tat to the basal transcriptional
machinery (22). Interestingly, we observed that CTIP2 is
also able to repress this functional cooperation (C. Marban
and O. Rohr, unpublished data). These results suggest that, in
this context, COUP-TF may bind CTIP2 via its N-terminal
region and the general transcription factor TFIIB via its C-
terminal part as described previously (39). Thus, in the
absence of Sp1-mediated linkage to the GC-box region of
the HIV-1 LTR, CTIP2 may bypass Sp1 association by a
COUP-TF-mediated linkage to the basal transcriptional
machinery. Moreover, this proposed indirect linkage might
be weak since it appeared undetectable by ChIP experiments.
Along this line, CTIP2 might also associate to some other
cellular transcription factors yet to be characterized.
These studies fully complete those reporting CTIP2-
mediated repression of the viral Tat function (25). Since
Sp1 or COUP-TF association is necessary for Tat function
in microglial cells (22), it can be postulated that CTIP2-
mediated impairment of Sp1 and COUP-TF function contrib-
utes to the previously observed repression of Tat function.
The chromatin structure at the site of provirus integration
is reminiscent to post-integration latency phenomenon (38).
In vitro, latent T-cell clones frequently contain HIV-1 genome
integrated in heterochromatin structures. This is in contrast to
a productive infection where integration in or near heterochro-
matin is disfavored (40). No antiretroviral drugs that are cur-
rently available can inhibit transcription of HIV RNA from the
integrated HIV proviral DNA in infected cells. Nevertheless,
HDAC inhibitors are able to induce quiescent provirus, sug-
gesting that derepression of heterochromatin structures may
force viral expression from latently infected reservoirs (41,42).
Thus, investigation on factors that may promote heterochro-
matin structures to the viral gene promoter, such as CTIP2,
appears crucial for understanding these phenomena and for the
development of new anti-HIV strategies. At this stage, further
studies will be necessary to precisely examine the CTIP2-
associated enzymatic activities that promote transcriptional
silencing. In addition, since our investigations were restricted
to the transcriptional step of the viral life cycle, it cannot be
excluded that CTIP2 also counteracts other critical steps
necessary to optimal viral replication. This possibility needs
further clarification.
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